Literature DB >> 16404261

Quantification of total and perfused blood vessels in murine skin autografts using a fluorescent double-labeling technique.

Siobhán O'Ceallaigh1, Sarah Elizabeth Herrick, Joanne Elizabeth Bluff, Duncan Angus McGrouther, Mark W J Ferguson.   

Abstract

BACKGROUND: Two theories exist regarding the revascularization of skin autografts: direct anastomosis between graft vessels and bed vessels, and ingrowth of bed vessels (angiogenesis) into the graft. This study characterizes revascularization, spatially and chronologically, in a murine skin autograft model using a double-labeling technique.
METHODS: Full-thickness (1 cm2) skin grafts were performed on adult male C57/Bl6 mice. After 48 hours, 60 hours, 3 days, 5 days, and 14 days (n = 3 mice per time point) terminal intracardiac perfusion with a fluorescein/dextran dye demonstrated vascular filling of graft blood vessels. Fluorescence immunohistochemistry of CD31+ endothelial cells allowed counting of total vessels and fluorescein perfusion quantification of patent vessels in the lateral graft area, central graft area, graft bed, and wound margins.
RESULTS: Initial filling of graft vessels was seen after 48 hours. This included vessels in the papillary dermis of the graft, and there was no significant difference in the percentage of filled vessels in the deep dermis of the graft compared with the papillary dermis of the graft. A rapid increase in vessel filling was seen between 48 and 60 hours in all areas of the graft. Vessel filling occurred mainly in the central area of the graft rather than in the lateral areas.
CONCLUSIONS: The short time course of vessel filling indicates that the initial onset of revascularization is attributable to early anastomoses between graft and bed vessels, mainly in the central area of the graft. These findings have implications for both autograft revascularization in a clinical setting and in the development of tissue-engineered skin substitutes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16404261     DOI: 10.1097/01.prs.0000185611.87601.b8

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

Review 1.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.

Authors:  Anthony D Metcalfe; Mark W J Ferguson
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

2.  Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis.

Authors:  Ashok N Babu; Tomohiro Murakawa; Joshua M Thurman; Edmund J Miller; Peter M Henson; Martin R Zamora; Norbert F Voelkel; Mark R Nicolls
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

3.  RNAi functionalized scaffold for scarless skin regeneration.

Authors:  Xing Liu; Lie Ma; Changyou Gao
Journal:  Organogenesis       Date:  2013-04-01       Impact factor: 2.500

4.  Microscopic and histological examination of the mouse hindpaw digit and flexor tendon arrangement with 3D reconstruction.

Authors:  Jason Wong; William Bennett; Mark W J Ferguson; Duncan A McGrouther
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

Review 5.  Molecular mediators of angiogenesis.

Authors:  Areck A Ucuzian; Andrew A Gassman; Andrea T East; Howard P Greisler
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

6.  Acute cutaneous wounds treated with human decellularised dermis show enhanced angiogenesis during healing.

Authors:  Nicholas S Greaves; Syed A Lqbal; Julie Morris; Brian Benatar; Teresa Alonso-Rasgado; Mohamed Baguneid; Ardeshir Bayat
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

7.  Angiogenesis and tissue formation driven by an arteriovenous loop in the mouse.

Authors:  Richard Wong; Roberto Donno; Christopher Y Leon-Valdivieso; Urmas Roostalu; Brian Derby; Nicola Tirelli; Jason K Wong
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.